Fitusiran Sodium Patent Expiration
Fitusiran Sodium was first introduced by Genzyme Corp
Fitusiran Sodium Patents
Given below is the list of patents protecting Fitusiran Sodium, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Qfitlia | US11091759 | Methods and compositions for treating a Serpinc1-associated disorder | Dec 07, 2036 | Genzyme Corp |
| Qfitlia | US9127274 | Serpinc1 iRNA compositions and methods of use thereof | Mar 22, 2033 | Genzyme Corp |
| Qfitlia | US9376680 | Serpinc1 iRNA compositions and methods of use thereof | Mar 15, 2033 | Genzyme Corp |
Fitusiran Sodium's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List